302 related articles for article (PubMed ID: 9811695)
1. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Kiernan RE; Freed EO
J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
4. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
[TBL] [Abstract][Full Text] [Related]
5. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products.
Henderson LE; Sowder R; Copeland TD; Smythers G; Oroszlan S
J Virol; 1984 Nov; 52(2):492-500. PubMed ID: 6333515
[TBL] [Abstract][Full Text] [Related]
6. Functional exchange of an oncoretrovirus and a lentivirus matrix protein.
Deminie CA; Emerman M
J Virol; 1994 Jul; 68(7):4442-9. PubMed ID: 8207817
[TBL] [Abstract][Full Text] [Related]
7. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
[TBL] [Abstract][Full Text] [Related]
8. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.
Wang CT; Zhang Y; McDermott J; Barklis E
J Virol; 1993 Dec; 67(12):7067-76. PubMed ID: 7693966
[TBL] [Abstract][Full Text] [Related]
9. Reverted HIV-1 Mutants in CD4
Lu W; Li TW; Phillips S; Wu L
Microbiol Spectr; 2021 Dec; 9(3):e0165321. PubMed ID: 34935422
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.
Ott DE; Chertova EN; Busch LK; Coren LV; Gagliardi TD; Johnson DG
J Virol; 1999 Jan; 73(1):19-28. PubMed ID: 9847302
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
[TBL] [Abstract][Full Text] [Related]
12. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions.
Denesvre C; Carrington C; Corbin A; Takeuchi Y; Cosset FL; Schulz T; Sitbon M; Sonigo P
J Virol; 1996 Jul; 70(7):4380-6. PubMed ID: 8676461
[TBL] [Abstract][Full Text] [Related]
13. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
Christodoulopoulos I; Cannon PM
J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562
[TBL] [Abstract][Full Text] [Related]
14. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.
Sparacio S; Pfeiffer T; Holtkotte D; Bosch V
Virology; 2002 Mar; 294(2):305-11. PubMed ID: 12009872
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
West JT; Weldon SK; Wyss S; Lin X; Yu Q; Thali M; Hunter E
J Virol; 2002 Apr; 76(7):3338-49. PubMed ID: 11884559
[TBL] [Abstract][Full Text] [Related]
16. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
Chen SS; Ferrante AA; Terwilliger EF
Virology; 1996 Dec; 226(2):260-8. PubMed ID: 8955046
[TBL] [Abstract][Full Text] [Related]
18. Interplay between single resistance-associated mutations in the HIV-1 protease and viral infectivity, protease activity, and inhibitor sensitivity.
Henderson GJ; Lee SK; Irlbeck DM; Harris J; Kline M; Pollom E; Parkin N; Swanstrom R
Antimicrob Agents Chemother; 2012 Feb; 56(2):623-33. PubMed ID: 22083488
[TBL] [Abstract][Full Text] [Related]
19. Molecular and phylogenetic analyses of a new amphotropic murine leukemia virus (MuLV-1313).
Howard TM; Sheng Z; Wang M; Wu Y; Rasheed S
Virol J; 2006 Dec; 3():101. PubMed ID: 17147829
[TBL] [Abstract][Full Text] [Related]
20. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.
Lee SK; Harris J; Swanstrom R
J Virol; 2009 Sep; 83(17):8536-43. PubMed ID: 19515760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
